Multiple plaque rupture and C-reactive protein in acute myocardial infarction

Atsushi Tanaka1, Kenei Shimada, Toshihiko Sano

  • 1Department of Cardiology, Baba Memorial Hospital, Sakai, Japan. m4497147@msic.med.osaka-cu.ac.jp

Insights

Multiple plaque ruptures in acute myocardial infarction (AMI) patients are linked to higher C-reactive protein (CRP) levels and a poorer prognosis. Treatment should address systemic inflammation, not just the culprit lesion.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Inflammation Research

Background:

  • Ruptured plaques can occur beyond the culprit lesion in acute coronary syndrome (ACS).
  • Culprit lesion plaque rupture is linked to elevated C-reactive protein (CRP) and poor prognosis in ACS.

Purpose of the Study:

  • To investigate the association between multiple plaque ruptures, CRP levels, and clinical outcomes in patients with acute myocardial infarction (AMI).

Main Methods:

  • Intravascular ultrasound (IVUS) was used to assess plaque rupture in 45 patients with first AMI.
  • IVUS examined infarct-related arteries and other major coronary arteries.

Main Results:

  • Multiple plaque ruptures were identified in 24% of patients.
  • Higher CRP levels correlated positively with the number of plaque ruptures (p < 0.01).
  • Patients with multiple plaque ruptures had a significantly poorer prognosis (p = 0.01).

Conclusions:

  • Multiple plaque rupture is associated with systemic inflammation and predicts a poor prognosis in AMI.
  • AMI management should include systemic stabilization strategies beyond culprit lesion treatment.
Abstract

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...